Arlene Trompczynski v. HHS - Tdap, Guillain-Barre syndrome (2014)
Case summary [AI summaries can sometimes make mistakes]
Arlene Trompczynski filed a petition on May 23, 2013, alleging that a tetanus-diphtheria-acellular pertussis (Tdap) vaccination she received on August 20, 2010 caused her to develop Guillain-Barré syndrome (GBS) and that she experienced the residual effects of this injury for more than six months. Respondent denied that the Tdap vaccination caused petitioner's GBS or any other injury.
Nonetheless, both parties agreed to a joint stipulation filed July 14, 2014 to settle the case. Special Master Hamilton-Fieldman found the stipulation reasonable and adopted it as the decision of the Court.
Petitioner received a lump sum of $125,000.00, representing compensation for all damages available under 42 U.S.C. § 300aa-15(a). The parties subsequently agreed to attorneys' fees and costs of $14,150.00, payable jointly to petitioner and her counsel, Ronald C.
Homer of Conway, Homer & Chin-Caplan, P.C. Petitioner had not personally incurred any out-of-pocket litigation expenses.
Theory of causation
Tdap Aug 20, 2010 → GBS (residual >6 months). Joint stipulation Jul 14, 2014; SM Hamilton-Fieldman. Comp $125,000. Fees $14,150 (Homer, Conway Homer & Chin-Caplan PC, Boston MA). All DB fields correct.
Source PDFs
USCOURTS-cofc-1_13-vv-00351